Associations amongst genes, molecules, cells, and organs in breast cancer metastasis
SD Nathanson, LC Dieterich, XHF Zhang… - Clinical & experimental …, 2024 - Springer
This paper is a cross fertilization of ideas about the importance of molecular aspects of
breast cancer metastasis by basic scientists, a pathologist, and clinical oncologists at the …
breast cancer metastasis by basic scientists, a pathologist, and clinical oncologists at the …
Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity
Platinum-based chemotherapeutics exhibit excellent antitumor properties. However, these
drugs cause severe side effects including toxicity, drug resistance, and lack of tumor …
drugs cause severe side effects including toxicity, drug resistance, and lack of tumor …
Microenvironmental Regulation of Dormancy in Breast Cancer Metastasis:“An Ally that Changes Allegiances”
Breast cancer remission after treatment is sometimes long-lasting, but in about 30% of
cases, there is a relapse after a so-called dormant state. Cellular cancer dormancy, the …
cases, there is a relapse after a so-called dormant state. Cellular cancer dormancy, the …
Epigenetic and pluripotency aspects of disseminated cancer cells during minimal residual disease
Our understanding of the minimal residual disease (MRD) in solid cancers indicates that it
can persist in the system for years or even decades. We now know that the persistence of …
can persist in the system for years or even decades. We now know that the persistence of …
A Live Tracker of Dormant Disseminated Tumor Cells
F Landum, AL Correia - Cancer Cell Dormancy: Methods and Protocols, 2024 - Springer
The high prevalence of dormant disseminated tumor cells (DTCs) persisting systemically in
patients with metastatic cancer is a major threat to long-lasting cure (Aguirre-Ghiso, Nat Rev …
patients with metastatic cancer is a major threat to long-lasting cure (Aguirre-Ghiso, Nat Rev …
Anti-angiogenic therapy-mediated endothelial damage: a driver of breast cancer recurrence?
L Pisarsky, CM Ghajar - … Mechanisms of Minimal Residual Disease and …, 2018 - Springer
Anti-angiogenic therapy was conceived originally as a silver bullet able to maintain tumor
dormancy indefinitely. By targeting new blood vessel formation, anti-angiogenic agents were …
dormancy indefinitely. By targeting new blood vessel formation, anti-angiogenic agents were …
[PDF][PDF] Epigenetic and Pluripotency Aspects of Disseminated Cancer Cells During Minimal Residual
MJ Carlini, N Shrivastava, MS Sosa - researchgate.net
Our understanding of the minimal residual disease (MRD) in solid cancers indicates that it
can persist in the system for years or even decades. We now know that the persistence of …
can persist in the system for years or even decades. We now know that the persistence of …